12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Cytos proposes private placement of convertible notes

Cytos Biotechnology AG (SIX:CYTN), Zurich, Switzerland
Business: Neurology, Inflammation, Cardiovascular
Date announced: 3/21/12
Type: Private placement of convertible notes
To be raised: CHF13.3 million ($14.4 million)
Shares outstanding...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >